
Insulin Lispro (Humalog)
Medication
- Lähetetään Saksasta
Tilaus
- DHL seurannalla
- Huomaamaton pakkaus
Yhdellä silmäyksellä
Insulin Lispro (Humalog) lukuina
Tietopankkimme keskeiset luvut.
Koko tietopankkiartikkeli- Class
- Rapid-acting insulin analogue
- Sizes
- 6ml/600iu1 size in the shop
What studies show
All 5 sources in the lexicon- Howey et al., Diabetes, 1994
- Anderson et al., Diabetes, 1997
- Brunelle et al., Diabetes Care, 1998
Arvostelut
Mitä asiakkaat sanovat
Vain todelliset tilaukset, joissa oli Insulin Lispro (Humalog).
Kaikki arvostelutTuotteelle Insulin Lispro (Humalog) ei ole vielä laboratorioanalyysia. Äänestä sitäKaikki laboratorioanalyysit
Tietoa
Kaikki aiheesta Insulin Lispro (Humalog)
Tarkemmat tiedot tulossa pian.
How does Insulin Lispro differ from regular insulin?
Two building blocks at positions B28 and B29 are swapped. The molecules therefore cluster much less and pass from the depot into the blood faster. In 10 healthy men the peak level came after 42 instead of 101 minutes and was more than twice as high. At the receptor Lispro acts like human insulin.
Is Insulin Lispro approved?
Yes. ChEMBL lists Insulin Lispro as an approved drug with first approval in 1996. On ClinicalTrials.gov more than 350 trials list Insulin Lispro among their interventions (as of 25 October 2026). Everything here is the state of research, not a recommendation.
What did the trial on injection timing show?
The trial varied the gap between injection and meal. The best control came with Lispro on average 22.5 minutes before eating, with regular insulin 63.8 minutes before. The lowest mean blood sugar was practically the same, the swings after eating were smaller with Lispro.
How often did hypoglycaemia occur?
In 1,008 patients with type 1 diabetes hypoglycaemia was 12 percent less frequent with Lispro than with regular insulin, most clearly at night. Across eight trials with more than 1,400 patient-years 3.1 percent had severe hypoglycaemia with Lispro versus 4.4 percent with regular insulin.
Does Lispro replace a basal insulin?
No, it complements it. In a trial with 66 patients over 5 months the basal insulin was adjusted as well after switching to Lispro, from 1.4 to 3.1 NPH injections a day on average. HbA1c fell from 8.8 to 8.0 percent and hypoglycaemia did not increase. The authors see the right basal insulin as the key.
What is the biggest risk?
Hypoglycaemia, a direct consequence of the main effect. The action window is short and steep, a skipped meal falls right into the peak. Even in the trials with diabetes and medical supervision a few percent of patients had severe hypoglycaemia.
Liittyvät
Samankaltaiset tuotteet
Telmisartan
Lääkkeet · Sydän ja verisuonet Sydän ja verisuonet
2 kokoa
Laboratoriotestattu
Ivermectin
Lääkkeet · Vatsa ja maksa Vatsa ja maksa
1 koko
Fenbendazol
Lääkkeet · Vatsa ja maksa Vatsa ja maksa
1 koko
Prednisone
Lääkkeet · Vatsa ja maksa Vatsa ja maksa
1 koko
Insulin Lispro (Humalog)